Tagged with CK Life Sciences

Melvin Toh – Executive Director, Vice President & Chief Scientific Officer, CK Life Sciences

Hong Kong Melvin Toh – Executive Director, Vice President & Chief Scientific Officer, CK Life Sciences

Hong Kong Following our conversation with CEO Lance Yuen on CK Life Sciences’ strategic direction, Chief Scientific Officer Melvin Toh now takes us inside the scientific engine driving that vision forward. He traces the organisation’s evolution from US-based acquisitions to a protein/peptide and circular RNA vaccine platform built in Hong Kong, explains…

Lance Yuen – Executive Director, Vice President & Chief Executive Officer, CK Life Sciences

Hong Kong Lance Yuen – Executive Director, Vice President & Chief Executive Officer, CK Life Sciences

Hong Kong CK Life Sciences, under the leadership of CEO Lance Yuen, is reshaping its identity through a renewed focus on early-stage oncology innovation powered by next-generation cancer vaccines, AI-enabled design and a growing network of regional partnerships. Stable commercial revenues give the organisation unusual freedom to pursue high conviction science, while…